ArticleTherapeutic advances in musculoskeletal disease2022

Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study.

Honghu Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.